Positive remote crossmatch: Impact on short-term and long-term outcome in cadaver renal transplantation

Transplantation

Volumn 75, Issue 4, 2003, Pages 501-505

  Noreen, Harriet J ^a   McKinley, Devin M ^a   Gillingham, Kristen J ^b   Matas, Arthur J ^b   Segall, Miriam ^b  

^a UNIVERSITY OF MINNESOTA MEDICAL CENTER   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN; IMMUNOSUPPRESSIVE AGENT;

ARTICLE; CROSS REACTION; EARLY DIAGNOSIS; GRAFT REJECTION; GRAFT SURVIVAL; HALF LIFE TIME; HLA MATCHING; HUMAN; HUMAN CELL; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; OUTCOMES RESEARCH; PREDICTION; PRIORITY JOURNAL; REMOTE CROSS MATCH; RISK ASSESSMENT; RISK FACTOR; SENSITIZATION; TREATMENT CONTRAINDICATION; TREATMENT OUTCOME;

ACUTE DISEASE; CADAVER; CHRONIC DISEASE; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY TESTING; HUMANS; KIDNEY TRANSPLANTATION; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; RISK FACTORS; TREATMENT OUTCOME;

EID: 0037468451     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000048225.98745.64     Document Type: Article

References (22)

1. Kissmeyer-Nielsen F, Olsen S, Peterson VP, et al. Hyperacute rejection of kidney allografts associated with pre-existing humoral antibodies against donor cells. Lancet 1965; i: 622.
2. Patel R, Terasaki PI. Significance of the positive crossmatch test in kidney transplantation. N Engl J Med 1969; 288: 735.
3. Cardella CJ, Falk JA, Nicholson, MJ, et al. Successful renal transplantation in patients with T-cell reactivity to donor. Lancet 1982; 2: 1240.
4. Kerman RH, Flechner SM, Van Buren CT, et al. Successful transplantation of cyclosporine-treated allograft recipients with serologically positive historical, but negative preoperative, donor crossmatches. Transplantation 1985; 40: 615.
5. Bollinger RR, Vaughn W, Sanfilippo F, et al. Results of the South-Eastern Organ Procurement Foundation strategy for transplanting sensitized patients. Transplant Proc 1987; 19: 1964.
6. Quinn T, Louis P, Mallis M, et al. A past positive crossmatch does not affect allograft survival for cyclosporine-immunosuppressed primary and secondary renal transplant recipients. Transplant Proc 1989; 21: 704.
7. Guerin C, Pomier G, Fleuru H, et al. Renal transplantation with positive allocrossmatch (B/T; historical/current) but current T negative. Transplant Proc 1991; 23: 417.
8. Schechner RS, Greenstein SM, Mallis ML, et al. Does a positive historical crossmatch affect long-term renal transplant graft survival? Transplant Proc 1991; 23: 415.
9. Cristol JP, Mourad G, Argiles A, et al. Negative crossmatch on current sera and good HLA matching are the main requirements for renal transplantation in highly sensitized patients. Transplant Proc 1992; 24: 2470.
10. Turka LA, Goguen JE, Carpenter CB, et al. The effect of historical crossmatches and sensitization on renal allograft survival. Transplant Proc 1989; 21: 696.
11. Opelz G. Relevance of "remote positive" crossmatches and positive B-cell crossmatches in renal transplantation. Transplant Proc 1990; 22: 1878.
12. Speiser D, Jeannet M. Renal transplantation to sensitized patients: decreased graft survival probability associated with a positive historical crossmatch. Transpl Immunol 1995; 3: 330.
13. Troppman C, Gillingham KJ, Benedetti E, et al. Delayed graft function, acute rejection, and outcome after cadaver renal transplantation. A multivariate analysis. Transplantation 1995; 59: 962.
14. Ojo AO, Wolfe RA, Held PJ, et al. Delayed graft function - risk factors and implications for renal allograft survival. Transplantation 1997; 63: 968.
15. Koning OH, Ploeg RJ, van Bockel JH, et al. Risk factors for delayed graft function in cadaveric kidney transplantation: a prospective study of renal function and graft survival after preservation with University of Wisconsin solution in multi-organ donors. Transplantation 1997; 63: 1620.
16. McLaren AJ, Jassem W, Gray DW, et al. Delayed graft function: risk factors and the relative effects of early function and acute rejection on long-term survival in cadaveric renal transplantation. Clin Transplant 1999; 13: 266.
17. Conti DJ, Freed BM, Gruber SA, et al. Impact of retransplant status on delayed graft function: an analysis of paired cadaver kidneys. Transplant Proc 1995; 27: 1070.
18. Feucht HE, Lederer SR, Kluth B. Humoral alloreactivity in recipients of renal allografts as a risk factor for the development of delayed graft function. Transplantation 1996; 65: 757.
19. Frommool S, Jhangri GS, Cockfield SM, et al. Time dependency of factors affecting renal allograft survival. J Am Soc Nephrol 2000; 11: 565.
20. Smits JMA, van Houwelingen HC, de Meester J, et al. Permanent detrimental effect of nonimmunological factors on long-term renal graft survival. Transplantation 2000; 70: 317.
21. Kerman R, Gebel H, Bray R, et al. HLA antibody and donor reactivity define patients at risk for rejection or graft loss. Am J Transpl 2002; 2(suppl 3): 258.
22. Avlonitis VS, Chidambaram V, Manas DM, et al. The relevance of donor T-cell directed immunoglobulin G in historic sera in the age of flow cytometry. Transplantation 2000; 70: 1260.